Conventional chemotherapeutics exploration is hampered due to their nonspecific
distribution leading to unintended serious toxicity. Toxicity is so severe that deciding to go for …

For the purpose of this review, active targeting in cancer research encompasses strategies
wherein a ligand for a cell surface receptor expressed on tumor cells is used to deliver a …

Small molecule nanodrugs consisting of pure drugs, drug‐drug dimers, drug‐drug
conjugates, or drug derivatives could realize drug delivery by themselves without the aid of …

Research on molecular targeted therapy of tumors is booming, and novel targeted therapy
drugs are constantly emerging. Small molecule targeted compounds, novel targeted therapy …

Traditional chemotherapy mostly relies on the use of cytotoxic agents, which are typically
unable to preferentially localize at the tumor microenvironment resulting in off-target toxicity …

Nanoparticles and macromolecular carriers have been widely used to increase the efficacy
of chemotherapeutics, largely through passive accumulation provided by the enhanced …

Chemotherapy is widely recognized as an effective approach for treating cancer due to its
ability to eliminate cancer cells using chemotherapeutic drugs. However, traditional …

Cancer is currently one of the major diseases that has gained a lot of scientific attention.
Conventional cancer therapeutics involve surgical removal of tumors from patients followed …

Nanomedicines based on synthetic polypeptides are among the most versatile and
advanced platforms for tumor therapy. Notably, several polypeptide-based nanodrugs are …

The advancement of tissue and cell-specific drug delivery systems is a key to precision
cancer therapy. Peptides, with easy synthesis, low immunogenicity and biological functions …